{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:37:27Z","timestamp":1768001847800,"version":"3.49.0"},"reference-count":44,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,6,10]],"date-time":"2002-06-10T00:00:00Z","timestamp":1023667200000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) were demonstrated to have important implications in the progression and invasiveness of many malignant disorders. In contrast, the biological significance of these molecules in human leukaemias is not clear. We determined the levels of MMP\u20102, MMP\u20109, TIMP\u20101 and TIMP\u20102 in the bone marrow of 37 patients with acute myelogenous leukaemia (AML) and 18 patients with acute lymphoblastic leukaemia (ALL) before chemotherapy. Nineteen bone marrow donors served as normal controls. After chemotherapy, sequential measurements were done during the course in 19 AML patients. The levels of TIMP\u20101 and TIMP\u20102 were significantly higher and MMP\u20109 levels were significantly lower in the AML and ALL patients than in the normal controls. MMP\u20102 levels were higher in ALL, but not AML patients, compared with controls. Moreover, the levels of marrow MMP\u20102 and MMP\u20109 did not parallel the numbers of leukaemic blasts in the peripheral blood. MMP\u20109 levels were significantly lower in the AML patients who achieved a complete remission (CR) than in those who did not (8\u00b771\u2003\u00b1\u20038\u00b715\u2003ng\/ml <jats:italic>vs<\/jats:italic> 26\u00b713\u2003\u00b1\u200327\u00b775\u2003ng\/ml, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b705). The AML patients with lower MMP\u20109 levels (\u2264\u20034\u00b74\u2003ng\/ml) tended to have longer survival time than those with higher levels (&gt;\u200312\u2003months <jats:italic>vs<\/jats:italic> 4\u2003months, <jats:italic>P\u2003=<\/jats:italic>\u20030\u00b712). In addition, MMP\u20109 levels in the AML patients at CR rose to the same range as the controls, but dropped again at relapse, demonstrating a close relationship of marrow MMP\u20109 with disease status of AML. Therefore, we conclude that the level of marrow MMP\u20109 may be a useful surrogate marker for monitoring disease status in AML and propose it as a potential prognostic factor.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03510.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:45:37Z","timestamp":1047365137000},"page":"835-841","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP\u20109 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia"],"prefix":"10.1111","volume":"117","author":[{"given":"Liang\u2010In","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong\u2010Tsamn","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi\u2010Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng\u2010Yeh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jih\u2010Luh","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwei\u2010Fang","family":"Tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,6,10]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"4120","article-title":"Stromelysin\u20103 is overexpressed by stromal elements in primary non\u2010small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts","volume":"55","author":"Anderson I.C.","year":"1995","journal-title":"Cancer Research"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V71.6.1720.1720","article-title":"K562 cells produce and respond to human erythroid\u2010potentiating activity","volume":"71","author":"Avalos B.R.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.336"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/10454411930040020401"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199205000-00009"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.17.1260"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.22.13453"},{"key":"e_1_2_6_9_1","first-page":"234","article-title":"Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression","volume":"14","author":"Crawford H.C.","year":"1994","journal-title":"Invasion and Metastasis"},{"key":"e_1_2_6_10_1","first-page":"239","article-title":"Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression","volume":"4","author":"D'Errico A.","year":"1991","journal-title":"Modern Pathology"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(93)90074-N"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/318066a0"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840515)53:10<2026::AID-CNCR2820531004>3.0.CO;2-Q"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(93)90024-X"},{"key":"e_1_2_6_15_1","first-page":"4548","article-title":"Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy","volume":"52","author":"Garbisa S.","year":"1992","journal-title":"Cancer Research"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/315768a0"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.156.1.1","article-title":"Matrix metalloproteinases in immunity","volume":"156","author":"Goetzl E.J.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_18_1","first-page":"3196","article-title":"Prognostic significance of circulating matrix metalloproteinase\u20102 to tissue inhibitor of metalloproteinases\u20102 ratio in recurrence of urothelial cancer after complete resection","volume":"56","author":"Gohji K.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2379::AID-CNCR17>3.0.CO;2-Y"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<96::AID-IJC18>3.0.CO;2-F"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V92.4.1342","article-title":"Tissue inhibitor of metalloproteinase (TIMP) \u20101 induces differentiation and an antiapoptotic phenotype in germinal center B cells","volume":"92","author":"Guedez L.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_22_1","first-page":"1945","article-title":"Spectrum of extracellular matrix degrading enzymes in normal and malignant T lymphocytes","volume":"19","author":"Hauzenberger D.","year":"1999","journal-title":"Anticancer Research"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.107.9.2373"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240513"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01352.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood.V77.11.2475.2475","article-title":"Tissue inhibitor of metalloproteinases\u20101 (TIMP\u20101) RNA is expressed at elevated levels in malignant non\u2010Hodgkin's lymphomas","volume":"77","author":"Kossakowska A.E.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_27_1","first-page":"19","article-title":"Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas","volume":"5","author":"Kossakowska A.E.","year":"1993","journal-title":"Oncology Research"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.2080"},{"key":"e_1_2_6_29_1","first-page":"5054","article-title":"Tumor invasion and metastasis: an imbalance of positive and negative regulation","volume":"51","author":"Liotta L.A.","year":"1991","journal-title":"Cancer Research"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01269887"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3293146.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0496&ndash;461"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.19.10863"},{"key":"e_1_2_6_34_1","first-page":"1336","article-title":"Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization","volume":"52","author":"Pyke C.","year":"1992","journal-title":"Cancer Research"},{"key":"e_1_2_6_35_1","first-page":"1115","article-title":"Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes","volume":"5","author":"Ries C.","year":"1999","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004320050161"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)80386-U"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.5.1708"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(92)90214-S"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(95)00084-4"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s005990050018"},{"key":"e_1_2_6_42_1","first-page":"384","article-title":"Differential expression of membrane\u2010type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro","volume":"56","author":"Yamamoto M.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_6_43_1","first-page":"475","article-title":"Type IV collagenase\/gelatinase (MMP\u20102) is not increased in plasma of patients with cancer","volume":"1","author":"Zucker S.","year":"1992","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"e_1_2_6_44_1","first-page":"140","article-title":"M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer","volume":"53","author":"Zucker S.","year":"1993","journal-title":"Cancer Research"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950815)76:4<700::AID-CNCR2820760426>3.0.CO;2-5"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03510.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03510.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03510.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:14:51Z","timestamp":1697429691000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03510.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03510.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03510.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"2002-06-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}